Literature DB >> 26836472

Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes.

Oier Aizpurua-Olaizola1,2, Umut Soydaner1, Ekin Öztürk1, Daniele Schibano1, Yilmaz Simsir1, Patricia Navarro2, Nestor Etxebarria2, Aresatz Usobiaga2.   

Abstract

The evolution of major cannabinoids and terpenes during the growth of Cannabis sativa plants was studied. In this work, seven different plants were selected: three each from chemotypes I and III and one from chemotype II. Fifty clones of each mother plant were grown indoors under controlled conditions. Every week, three plants from each variety were cut and dried, and the leaves and flowers were analyzed separately. Eight major cannabinoids were analyzed via HPLC-DAD, and 28 terpenes were quantified using GC-FID and verified via GC-MS. The chemotypes of the plants, as defined by the tetrahydrocannabinolic acid/cannabidiolic acid (THCA/CBDA) ratio, were clear from the beginning and stable during growth. The concentrations of the major cannabinoids and terpenes were determined, and different patterns were found among the chemotypes. In particular, the plants from chemotypes II and III needed more time to reach peak production of THCA, CBDA, and monoterpenes. Differences in the cannabigerolic acid development among the different chemotypes and between monoterpene and sesquiterpene evolution patterns were also observed. Plants of different chemotypes were clearly differentiated by their terpene content, and characteristic terpenes of each chemotype were identified.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26836472     DOI: 10.1021/acs.jnatprod.5b00949

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  83 in total

1.  Gene Networks Underlying Cannabinoid and Terpenoid Accumulation in Cannabis.

Authors:  Jordan J Zager; Iris Lange; Narayanan Srividya; Anthony Smith; B Markus Lange
Journal:  Plant Physiol       Date:  2019-05-28       Impact factor: 8.340

Review 2.  Reciprocal Influences of HIV and Cannabinoids on the Brain and Cognitive Function.

Authors:  Sheri L Towe; Christina S Meade; Christine C Cloak; Ryan P Bell; Julian Baptiste; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2020-05-22       Impact factor: 4.147

Review 3.  The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2.

Authors:  Makenzie L Fulmer; Douglas P Thewke
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2018

4.  Barriers to the wider adoption of medicinal Cannabis.

Authors:  Stephen Ph Alexander
Journal:  Br J Pain       Date:  2020-05-29

5.  Clinical Pharmacokinetics of Cannabinoids and Potential Drug-Drug Interactions.

Authors:  Marta Vázquez; Carlos García-Carnelli; Cecilia Maldonado; Pietro Fagiolino
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Cannabinoids as anticancer therapeutic agents.

Authors:  Olga Kovalchuk; Igor Kovalchuk
Journal:  Cell Cycle       Date:  2020-04-05       Impact factor: 4.534

Review 7.  The Essential Medicinal Chemistry of Cannabidiol (CBD).

Authors:  Kathryn M Nelson; Jonathan Bisson; Gurpreet Singh; James G Graham; Shao-Nong Chen; J Brent Friesen; Jayme L Dahlin; Matthias Niemitz; Michael A Walters; Guido F Pauli
Journal:  J Med Chem       Date:  2020-09-10       Impact factor: 7.446

8.  Cannabinoid Receptors and Ligands: Lessons from CNS Disorders and the Quest for Novel Treatment Venues.

Authors:  Clara M Vecchini Rodríguez; Yma Escalona Meléndez; Jacqueline Flores-Otero
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Navigating Blind in the Green Rush: Clinical Considerations and Harm Reduction Practices for Cannabis.

Authors:  Brienna N Meffert; Danielle M Morabito; Michelle K Mosich; Mallory J Loflin; James Sottile; Adrienne J Heinz
Journal:  Curr Drug Res Rev       Date:  2019

10.  Cannabis and Mood Disorders.

Authors:  Aliya M Lucatch; Alexandria S Coles; Kevin P Hill; Tony P George
Journal:  Curr Addict Rep       Date:  2018-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.